Factors Associated with Intention to Receive the TAK-003 Dengue Vaccine Among Adults in Endemic Regions of Peru: A Cross-Sectional Study

Background: Dengue vaccination is a promising preventive strategy. Peru introduced the TAK-003 vaccine in November 2024 for children aged 10–16 years and expanded it in January 2026 to individuals aged 10–20 years and selected priority adult groups. This study evaluated perceptions and intention to...

Descripción completa

Detalles Bibliográficos

Autores principales:	Jose Armando Gonzales Zamora, Julieta M. Araoz-Salinas, Carlos Quispe‐Vicuña, Gabriel Aquino-Sandoval, Martin Ernesto Reategui-Garcia, Allison Nicole Ortiz-Pardo, Abraham De-Los-Ríos-Pinto, Noelia Morocho-Alburqueque, Silvia Celeste Tipe-Gonzales, Wagner Rios-García, Anderson Nelver Soriano-Moreno, Brando Ortiz-Saavedra, José Miguel Rios-Osorio, Ruth Ramon-Tapia, Jorge Alave
Formato:	Artículo
Lenguaje:	inglés
Publicado:	2026
Materias:	dengue vaccine TAK-003 vaccination intention vaccine hesitancy vaccine perception vaccine information adults dengue-endemic regions Peru health education healthcare professional recommendations Vaccine Coverage and Hesitancy Mosquito-borne diseases and control Dengue and Mosquito Control Research
Acceso en línea:	Enlace permanente (DOI o Handle)
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!